Status:
RECRUITING
Prospective Data Collection Initiative on Thoracic Malignancies
Lead Sponsor:
Dutch Society of Physicians for Pulmonology and Tuberculosis
Conditions:
Lung Cancer
Thoracic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Survival after cancer diagnosis strongly depends on local tumor extent, lymph node involvement and the presence of distant metastases. However, there remains great inter-patient variability regarding ...
Detailed Description
Objective: * To start a prospective observational cohort study of patients with thoracic malignancies from their primary diagnosis until death. * After obtaining informed consent, to prospectively co...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Histo/cytopathological proof of a thoracic malignancy, or a strong suspicion (after imaging and multidisciplinary board);
- Informed consent for longitudinal observational data collection;
Exclusion
- Mentally challenged patients that are unable to provide conscientious informed consent as determined by the investigator.
- Inability to provide a written or electronic informed consent.
Key Trial Info
Start Date :
August 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
12000 Patients enrolled
Trial Details
Trial ID
NCT06996249
Start Date
August 15 2025
End Date
January 1 2030
Last Update
December 12 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Meander MC
Amersfoort, Netherlands, 3813TZ
2
MUMC+
Maastricht, Netherlands, 6229HX
3
CWZ (Canisius Wilhelmina Ziekenhuis)
Nijmegen, Netherlands, 6532SZ
4
Erasmus MC
Rotterdam, Netherlands, 3015GD